ISO 2631-1
Whole-Body Vibration Exposure Assessment
ISO 2631-1 establishes methods for measuring and evaluating human exposure to whole-body vibration in vehicles, buildings, and occupational environments. This test quantifies vibration acceleration over frequency ranges relevant to human physiology, assessing potential health effects and comfort levels. Industries including transportation, construction, and industrial manufacturing rely on this assessment to ensure worker safety and product quality. Accreditation ensures reliable measurement data for compliance with occupational health directives and product design standards across Europe.
What it measures
- Vibration acceleration in three orthogonal axes (X, Y, Z)
- Frequency-weighted vibration magnitude (1–80 Hz)
- Daily vibration exposure index (A(8))
- Peak acceleration and crest factor
- Comfort and health effect zones
🇩🇪
DIN EN ISO 2631-2
🇬🇧
BS EN ISO 2631-2
🇫🇷
NF EN ISO 2631-2
🇮🇹
UNI EN ISO 2631-2
🇪🇸
UNE EN ISO 2631-2
🇳🇱
NEN EN ISO 2631-2
🇩🇪
DIN EN ISO 5349-1
🇬🇧
BS EN ISO 5349-1
🇫🇷
NF EN ISO 5349-1
🇮🇹
UNI EN ISO 5349-1
🇪🇸
UNE EN ISO 5349-1
🇳🇱
NEN EN ISO 5349-1
1,817
Accredited labs
19
Countries
Showing 851–875 of 961 labs
ADP
Arachidonsäure
Kollagen/Epinephrin
Ristocetin
Expression aktivierungsabhängiger
+ 3 more
HbA1c
Aldosteron
Cortisol
APCR- Resistenz
Cardiolipin-AK IgG
+ 3 more
Universitätsklinikum des Saarlandes Institut für Klinische Hämostaseologie und Transfusionsmedizin
Active
freies Hämoglobin
Erythrozyten
Hämatokrit
Hämoglobin
Kleines Differential-Blutbild
+ 3 more
Urinsediment
Lamotrigin
HbA1c
Erythrozyten
Aripiprazol
+ 3 more
Familiäre Adenomatöse Polyposis
Syndrome (APC, MUTYH)
STK11, SMAD4 ), TruRisk® -Panel [SNV, CN
Familiäre Polyposis-Syndrome [FAP]
(APC, MUTYH)
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
alpha-Aminobuttersäure
Mianserin
Arginin
Asparagin
Asparaginsäure
+ 3 more
Candida spp.-Antikörper
Cardiolipin-Antikörper
Meningitiserreger-Ag (E. coli
Staphylococcus aureus
Treponema pallidum-Antikörper
+ 3 more
Granulozytäre Antikörper
(Screening und Differenzierung)
HLA spezifische Antikörper
B-Streptokokken (Screening)
Ektoparasiten (Differenzierung)
+ 3 more
Anti-Thyreoglobulin-Antikörper
[Anti-TG]
Anti-Thyreoperoxidase Antikörper
[Anti-TPO]
Anti-TSH-Rezeptor Antikörper
+ 3 more
angeborener Chromosomensatz
Silver-Russell-Syndrom:
H19, KCNQ1OT1
MEST
Deletion; Angelman-Syndrom
+ 3 more
5-Hydroxyindolessigsäure
Amitriptylin/Nortriptylin
Cyclosporin A
Gesamt-Itraconazol
Metanephrine, Normetanephrine
+ 3 more
IEC 60061-1
IEC 60061-2
IEC 60238
IEC 61184
IEC 60400
+ 3 more
ASTM D3575
ASTM D642
DIN 55440-1
DIN EN ISO 12048
DIN EN ISO 2234
+ 3 more
Myopathie, Nemaline (TyP1, 3-10:
ASTM E 23-18
ASTM D 1322
Toxizität UGT1A1-Gen rs3064744, rs414832
DIN EN 1789
+ 3 more
DIN EN 61466-1
DIN EN 61466-2
DIN 14678
DIN EN 54-2/A1
DIN EN 543
+ 3 more
Vectoflow
Active
am Standort Vectoflow Windtunnel A, Frie
Strömungsgeschwindigkeit
von Gasen 15 m/s bis
> 38 m/s
DIN EN ISO 7458
DIN EN ISO 7459
DIN EN ISO 8106
DIN EN 29008
DIN EN 29009
+ 3 more
VDE 0468-2-2
IEC 60068-2-2
VDE 0468-2-6
IEC 60068-2-6
DIN EN 60068-2-14
+ 3 more
Blutbild, kleines (Erythrozyten, Leukozy
Erythrozyten
Leukozyten
Retikulozyten
Thrombozyten
+ 3 more
Vistec Electron Beam
Active
− Permanentes Laboratorium
Positionen und Abstände
gleichgerichteter Kanten
positionen von Strukturen
(Hartschichtmasken)
+ 3 more
No matching labs found.